StockDrifts LogoStockDrifts

Neurofit 380550

Company
뉴로핏Neurofit
Insiders
2
Buys
4
Total Value
₩43M ($30K)
Avg Return
-8.56%
Last Filing
2026-05-29

Neurofit (380550) has 4 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩43M ($30K) in reported transaction value. The earliest filing StockDrifts holds for Neurofit is dated 2025-07-25; the most recent is 2026-05-29. Across these filings the average return since disclosure is -8.56%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-05-29BUYMarket Buy
빈준길
Binjungil
Co-CEO762₩14,480-8.6%₩11M ($8K)
2026-05-29BUYMarket Buy
김동현
Donghyun Kim
Co-CEO1.0K₩14,480-8.6%₩14M ($10K)
2026-05-29BUYMarket Buy
빈준길
Binjungil
Co-CEO238₩14,480-8.6%₩3M ($2K)
2026-05-29BUYMarket Buy
빈준길
Binjungil
Co-CEO1.0K₩14,480-8.6%₩14M ($10K)
2026-04-30BUY주식매수선택권
김창일
Kim Chang-il
vice president21.3K₩20,100+0.0%₩428M ($297K)
2025-10-17BUY주식매수선택권
임현국
Lim Hyeon-guk
Managing Director29.6K₩21,000+39.3%₩622M ($432K)
2025-10-17BUY주식매수선택권
임현국
Lim Hyeon-guk
Managing Director14.6K₩21,000+39.3%₩307M ($214K)
2025-08-12BUY주식매수선택권
임현국
Lim Hyeon-guk
Managing Director15.0K₩14,990+95.1%₩225M ($156K)
2025-07-25BUY신규상장
빈준길
Binjungil
Co-CEO1.2M₩20,300+44.1%₩24.1B ($16.7M)
2025-07-25BUY신규상장
김동현
Donghyun Kim
Co-CEO1.8M₩20,300+44.1%₩36.1B ($25.1M)

Frequently asked questions

Who has been buying Neurofit stock?
2 distinct insiders have filed 4 disclosed insider purchases in Neurofit (380550), most recently on 2026-05-29. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Neurofit have?
Neurofit has 4 buy-side and 0 sell-side disclosures on record, covering ₩43M ($30K) in total reported value, spanning 2025-07-25 to 2026-05-29.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.